OPTIMIZERx Corp
NASDAQ:OPRX

Watchlist Manager
OPTIMIZERx Corp Logo
OPTIMIZERx Corp
NASDAQ:OPRX
Watchlist
Price: 14.24 USD -2.8% Market Closed
Market Cap: 265.4m USD

OPTIMIZERx Corp
Investor Relations

OptimizeRx Corp. is digital health company, engaging in the provision of digital health messaging via electronic health records, which serve as a direct channel for pharmaceutical companies to communicate with healthcare providers. The company is headquartered in Rochester, Michigan and currently employs 97 full-time employees. The company went IPO on 2005-05-18. The firm enables engagement between life sciences organizations, healthcare providers and patients. The company connects approximately 60% of United States healthcare providers and their patients through a technology platform embedded within its own point-of-care network. The firm principal solutions and applications include financial messaging, brand therapeutic support messaging, and brand support. Its financial messaging enables doctors and staffs to access a universe of sample voucher, co-pay coupons and other patient support option through their electronic medical records (EMR) and/or e-prescribe system. Its brand messaging service includes brands awareness message, reminder advertisement, therapeutic support and unbranded messages. Its brand support is focused on educating and working with pharmaceuticals manufacturer on identifying, formulation and implementing new eRx media strategy for promoting their solutions.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q3 2025
Call Date
Nov 6, 2025
AI Summary
Q3 2025

Visibility & Guidance: Management emphasized improved visibility into future revenues thanks to a shift toward more predictable, contracted revenue models, allowing them to provide guidance out to 2026.

Revenue Smoothing: The shift away from periodic or lumpy revenue and toward renewable, subscription-like revenues has made quarterly revenues more consistent and predictable.

Conservative Guidance: Guidance for the remainder of the year and 2026 is based only on contracted revenues, with no contributions assumed from potential pipeline deals or the new Lamar partnership.

Gross Margin Expansion: Gross margin increased in the third quarter, driven by favorable product and channel partner mix, as well as growth in higher-margin platform businesses.

RFP & Client Demand: Both DTC and HCP client demand remain healthy, with stronger RFP activity and an improving win rate due to better-targeted offerings.

Mid-Tier Client Growth: There is notable growth in mid-tier clients, attributed to the company’s technology enabling these clients to compete more effectively.

Operating Expenses: Operating expenses stayed stable, with increases tied mostly to variable compensation from overperformance, and management expects a steady run rate moving forward.

Key Financials
Gross Margin
upper 50s to low 60s %
Operating Expenses
up about $2 million vs last year (on cash basis)
Net Revenue Retention (implied)
85–95%
Earnings Call Recording
Other Earnings Calls

Management

Mr. William J. Febbo
CEO & Director
No Bio Available
Mr. Stephen L. Silvestro
President
No Bio Available
Mr. Edward Stelmakh C.M.A., M.B.A.
CFO & COO
No Bio Available
Mr. Andrew Jacob D'Silva
Senior Vice President of Corporate Finance
No Bio Available
Ms. Marion K Odence-Ford
General Counsel & Chief Compliance Officer
No Bio Available
Ms. Maira Alejandra
Media Relations Manager
No Bio Available
Ms. Sheryl Kearney
Human Resources Manager
No Bio Available
Mr. Terence J. Hamilton
Senior Vice President of Pharma
No Bio Available
Dr. Doug Besch
Chief Product Officer
No Bio Available
Ms. Theresa Greco
Chief Commercial Officer
No Bio Available

Contacts

Address
MICHIGAN
Rochester
400 Water St Ste 200
Contacts
+12486516558.0
www.optimizerx.com